Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMC 34651)

Published in Proc Natl Acad Sci U S A on June 12, 2001

Authors

H Mizuno1, Z Fujimoto, H Atoda, T Morita

Author Affiliations

1: Department of Biotechnology, National Institute of Agrobiological Resources, Tsukuba, Ibaraki 305-8602, Japan. mizuno@nias.affrc.go.jp

Articles citing this

Anticoagulant proteins from snake venoms: structure, function and mechanism. Biochem J (2006) 1.11

Dynamical view of membrane binding and complex formation of human factor VIIa and tissue factor. J Thromb Haemost (2010) 1.07

Capturing spontaneous partitioning of peripheral proteins using a biphasic membrane-mimetic model. J Phys Chem B (2011) 0.95

Crystal structure of rhodocytin, a ligand for the platelet-activating receptor CLEC-2. Protein Sci (2008) 0.93

The linker connecting the two kringles plays a key role in prothrombin activation. Proc Natl Acad Sci U S A (2014) 0.89

Understanding selectivity of hard and soft metal cations within biological systems using the subvalence concept. I. Application to blood coagulation: direct cation-protein electronic effects vs. indirect interactions through water networks. J Chem Theory Comput (2010) 0.88

Snake-venom-derived Factor IX-binding protein specifically blocks the gamma-carboxyglutamic acid-rich-domain-mediated membrane binding of human Factors IX and X. Biochem J (2007) 0.88

Efficient Exploration of Membrane-Associated Phenomena at Atomic Resolution. J Membr Biol (2015) 0.87

Crystal structure of a platelet-agglutinating factor isolated from the venom of Taiwan habu (Trimeresurus mucrosquamatus). Biochem J (2004) 0.81

Effect of metal ion substitutions in anticoagulation factor I from the venom of Agkistrodon acutus on the binding of activated coagulation factor X and on structural stability. J Biol Inorg Chem (2009) 0.80

Binding of Ca2+ and Zn2+ to factor IX/X-binding protein from venom of Agkistrodon halys Pallas: stabilization of the structure during GdnHCl-induced and thermally induced denaturation. J Biol Inorg Chem (2010) 0.78

Naja naja atra venom ameliorates pulmonary fibrosis by inhibiting inflammatory response and oxidative stress. BMC Complement Altern Med (2014) 0.78

Computational study of coagulation factor VIIa's affinity for phospholipid membranes. Eur Biophys J (2006) 0.77

Metal ion binding to anticoagulation factor II from the venom of Agkistrodon acutus: stabilization of the structure and regulation of the binding affinity to activated coagulation factor X. J Biol Inorg Chem (2011) 0.77

The role of Ca(2+) ions in the complex assembling of protein Z and Z-dependent protease inhibitor: A structure and dynamics investigation. Bioinformation (2012) 0.76

ADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural Overview. Toxins (Basel) (2016) 0.76

Quantifying vitamin K-dependent holoprotein compaction caused by differential γ-carboxylation using high-pressure size exclusion chromatography. Anal Biochem (2015) 0.76

Identification of 31 novel mutations in the F8 gene in Spanish hemophilia A patients: structural analysis of 20 missense mutations suggests new intermolecular binding sites. Blood (2008) 0.75

Retargeting FX-binding-ablated HAdV-5 to vascular cells by inclusion of the RGD-4C peptide in hexon hypervariable region 7 and the HI loop. J Gen Virol (2016) 0.75

Crystallization and preliminary X-ray analysis of coagulation factor IX-binding protein from habu snake venom at pH 6.5 and 4.6. Acta Crystallogr Sect F Struct Biol Cryst Commun (2004) 0.75

Metalloproteases Affecting Blood Coagulation, Fibrinolysis and Platelet Aggregation from Snake Venoms: Definition and Nomenclature of Interaction Sites. Toxins (Basel) (2016) 0.75

Dramatic and concerted conformational changes enable rhodocetin to block α2β1 integrin selectively. PLoS Biol (2017) 0.75

Lipid Specificity of the Membrane Binding Domain of Coagulation Factor X. J Thromb Haemost (2017) 0.75

Articles cited by this

The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88

Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28

Structural mechanisms for domain movements in proteins. Biochemistry (1994) 5.36

3D domain swapping: a mechanism for oligomer assembly. Protein Sci (1995) 4.96

The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature (1996) 3.40

Structure of human des(1-45) factor Xa at 2.2 A resolution. J Mol Biol (1993) 2.07

Planar stacking interactions of arginine and aromatic side-chains in proteins. J Mol Biol (1994) 1.97

Protease inhibitors: current status and future prospects. J Med Chem (2000) 1.95

Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood (1999) 1.91

Wet and dry interfaces: the role of solvent in protein-protein and protein-DNA recognition. Structure (1999) 1.82

Biochemistry and physiology of blood coagulation. Thromb Haemost (1999) 1.77

Peptide exosite inhibitors of factor VIIa as anticoagulants. Nature (2000) 1.77

X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B. Proc Natl Acad Sci U S A (1995) 1.58

The Ca2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1. Biochemistry (1992) 1.37

The active site of blood coagulation factor Xa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex. J Biol Chem (1987) 1.36

Analysis of protein-protein interactions and the effects of amino acid mutations on their energetics. The importance of water molecules in the binding epitope. J Mol Biol (1997) 1.22

Structure of the Ca(2+)-free Gla domain sheds light on membrane binding of blood coagulation proteins. Nat Struct Biol (1995) 1.20

Structure of coagulation factors IX/X-binding protein, a heterodimer of C-type lectin domains. Nat Struct Biol (1997) 1.11

The primary structure of coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. Homology with asialoglycoprotein receptors, proteoglycan core protein, tetranectin, and lymphocyte Fc epsilon receptor for immunoglobulin E. J Biol Chem (1991) 1.08

Structure of the calcium ion-bound gamma-carboxyglutamic acid-rich domain of factor IX. Biochemistry (1995) 1.07

Structural basis for chemical inhibition of human blood coagulation factor Xa. Proc Natl Acad Sci U S A (1998) 1.07

The importance of specific gamma-carboxyglutamic acid residues in prothrombin. Evaluation by site-specific mutagenesis. J Biol Chem (1993) 0.99

Crystal structure of coagulation factor IX-binding protein from habu snake venom at 2.6 A: implication of central loop swapping based on deletion in the linker region. J Mol Biol (1999) 0.98

Coagulation factor X-binding protein from Deinagkistrodon acutus venom is a Gla domain-binding protein. Biochemistry (1998) 0.97

Blood coagulation factor IX-binding protein from the venom of Trimeresurus flavoviridis: purification and characterization. J Biochem (1995) 0.96

Evolution of Ca(2+)-dependent animal lectins. Prog Nucleic Acid Res Mol Biol (1993) 0.93

Vitamin K-dependent proteins. Vitam Horm (2000) 0.91

Protein structural requirements and properties of membrane binding by gamma-carboxyglutamic acid-containing plasma proteins and peptides. J Biol Chem (1989) 0.89

A family with hereditary factor X deficiency with a point mutation Gla32 to Gln in the Gla domain (factor X Tokyo). Br J Haematol (1999) 0.78

Articles by these authors

Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. Mol Cell (1998) 9.85

Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation (1983) 4.70

Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. Circ Res (1995) 4.55

The mouse RecA-like gene Dmc1 is required for homologous chromosome synapsis during meiosis. Mol Cell (1998) 3.22

Artificial surfactant therapy in hyaline-membrane disease. Lancet (1980) 3.21

Structural organizations of replicon domains during DNA synthetic phase in the mammalian nucleus. Exp Cell Res (1986) 3.17

The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab (1995) 2.32

Nucleotide sequence of the staphylocoagulase gene: its unique COOH-terminal 8 tandem repeats. J Biochem (1987) 2.21

Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res (2000) 2.14

Cell cycle-dependent expression of the mouse Rad51 gene in proliferating cells. Mol Gen Genet (1996) 2.00

Phase-sensitive observation of a spin-orbital Mott state in Sr2IrO4. Science (2009) 1.97

A carbonic anhydrase from the nacreous layer in oyster pearls. Proc Natl Acad Sci U S A (1996) 1.97

New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase. J Biochem (1977) 1.96

Chromogenic substrates for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins. Haemostasis (1978) 1.96

RAD51 and DMC1 form mixed complexes associated with mouse meiotic chromosome cores and synaptonemal complexes. J Cell Biol (1999) 1.81

Cloning and sequence of the human RecA-like gene cDNA. Nucleic Acids Res (1993) 1.81

Isolation of cDNAs for DNA-binding proteins which specifically bind to a tax-responsive enhancer element in the long terminal repeat of human T-cell leukemia virus type I. J Virol (1991) 1.80

A novel antagonist, No. 7943, of the Na+/Ca2+ exchange current in guinea-pig cardiac ventricular cells. Br J Pharmacol (1996) 1.79

The mouse and human homologs of DMC1, the yeast meiosis-specific homologous recombination gene, have a common unique form of exon-skipped transcript in meiosis. Nucleic Acids Res (1996) 1.75

The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutat Res (1990) 1.63

Highly sensitive peptide-4-methylcoumaryl-7-amide substrates for blood-clotting proteases and trypsin. Eur J Biochem (1988) 1.62

The amino acid sequence of the procoagulant- and prothrombin-binding domain isolated from staphylocoagulase. J Biol Chem (1986) 1.60

Purification and characterization of Staphylococcus aureus FRI 1169 and 587 toxic shock syndrome exotoxins. Infect Immun (1984) 1.59

Reactivation of chickenpox contracted in infancy. Arch Dis Child (1995) 1.52

"Giant" colon lipoma: what kind of findings are necessary for the indication of endoscopic resection? Am J Gastroenterol (2001) 1.51

Validity of the palliative performance scale from a survival perspective. J Pain Symptom Manage (1999) 1.51

Tumors of peripheral nerves: correlation of symptoms, clinical signs, imaging features, and histologic diagnosis. Skeletal Radiol (1999) 1.49

Familial juvenile parkinsonism: clinical and pathologic study in a family. Neurology (1994) 1.46

Nucleotide sequence of the phoS gene, the structural gene for the phosphate-binding protein of Escherichia coli. J Bacteriol (1984) 1.45

Estramustine phosphate withdrawal syndrome with dramatic pain relief. J Urol (1999) 1.45

Regional cerebral oxygen saturation during electroconvulsive therapy: monitoring by near-infrared spectrophotometry. Anesth Analg (1996) 1.45

Structure and development of the glomerular crescent. Am J Pathol (1973) 1.44

Nucleotide sequence of a full-length cDNA for human fibroblast poly(ADP-ribose) polymerase. Biochem Biophys Res Commun (1987) 1.42

Cecal ligation and puncture peritonitis model shows decreased nicotinic acetylcholine receptor numbers in rat muscle: immunopathologic mechanisms? Anesthesiology (1999) 1.41

The differential effects of prostaglandin E1 and nitroglycerin on regional cerebral oxygenation in anesthetized patients. Anesth Analg (1997) 1.40

Re: Biochemical dehydration and fluid retention symptoms in terminally ill cancer patients whose death is impending. J Palliat Care (1998) 1.39

Intraoperative QRS-interval changes caused by hyperkalaemia in an infant with Arima syndrome. Paediatr Anaesth (1998) 1.39

Second gas effect of N2O on oxygen uptake. Can J Anaesth (2000) 1.39

Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events. J Cell Biol (1994) 1.36

Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells. Biochem Biophys Res Commun (1990) 1.35

In vitro and in vivo potentiation of radiosensitivity of malignant gliomas by antisense inhibition of the RAD51 gene. Biochem Biophys Res Commun (1998) 1.34

Good death in cancer care: a nationwide quantitative study. Ann Oncol (2007) 1.34

Angioma serpiginosum: a report of 2 cases identified using epiluminescence microscopy. Arch Dermatol (1999) 1.31

Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma. Am J Hematol (2001) 1.30

Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET. J Nucl Med (2000) 1.28

Interaction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: implication of cytoplasmic function of EBNA-LP. J Virol (2000) 1.28

Synthesis of antibody by spleen cells after exposure to kiloroentgen doses of ionizing radiation. J Cell Physiol (1967) 1.28

Both the wild type and a functional isoform of CFTR are expressed in kidney. Am J Physiol (1996) 1.27

Lipopolysaccharide-sensitive serine-protease zymogen (factor C) found in Limulus hemocytes. Isolation and characterization. Eur J Biochem (1986) 1.26

Methimazole-induced agranulocytosis in Japanese patients with Graves' disease. Clin Endocrinol (Oxf) (1989) 1.26

Hyperproduction of phosphate-binding protein, phoS, and pre-phoS proteins in Escherichia coli carrying a cloned phoS gene. Eur J Biochem (1983) 1.25

Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol (1998) 1.24

A simple quantitative method to assess the in vitro engulfing and degradative potentials of mouse peritoneal phagocytic cells. J Reticuloendothel Soc (1965) 1.23

Calvasculin, as a factor affecting the microfilament assemblies in rat fibroblasts transfected by src gene. FEBS Lett (1993) 1.23

Enzymatic properties of staphylothrombin, an active molecular complex formed between staphylocoagulase and human prothrombin. J Biochem (1985) 1.20

Coagulation factor X activating enzyme from Russell's viper venom (RVV-X). A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains. J Biol Chem (1992) 1.20

Intracellular localization and metabolism of DNA polymerase alpha in human cells visualized with monoclonal antibody. Exp Cell Res (1984) 1.20

Organic phosphorus compounds. 1. 4-(Benzothiazol-2-yl)benzylphosphonate as potent calcium antagonistic vasodilator. J Med Chem (1986) 1.19

Late development of bile duct cancer after sphincteroplasty: a ten- to twenty-two-year follow-up study. Surgery (1997) 1.19

Correlation of lifting versus non-lifting and microscopic depth of invasion in early colorectal cancer. Gastrointest Endosc (1999) 1.19

Psychotherapy for depression among incurable cancer patients. Cochrane Database Syst Rev (2008) 1.18

Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Arch Orthop Trauma Surg (2000) 1.16

Amino acid sequence of the nonsecretory ribonuclease of human urine. Biochemistry (1988) 1.16

The voice of the most vulnerable: lessons from the nuclear crisis in Fukushima, Japan. Bull World Health Organ (2012) 1.16

Diversity of Cl(-) channels. Cell Mol Life Sci (2006) 1.15

The association of ATR protein with mouse meiotic chromosome cores. Chromosoma (1999) 1.14

Effects of antifungal agents on ergosterol biosynthesis in Candida albicans and Trichophyton mentagrophytes: differential inhibitory sites of naphthiomate and miconazole. J Invest Dermatol (1985) 1.14

In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring. Environ Mol Mutagen (2000) 1.13

Antisense inhibition of the RAD51 enhances radiosensitivity. Biochem Biophys Res Commun (1996) 1.13

Effects of hypothermic and normothermic cardiopulmonary bypass on brain oxygenation. Ann Thorac Surg (1999) 1.12

Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro. Biochem Biophys Res Commun (1994) 1.12

Isolation and characterization of staphylocoagulase chymotryptic fragment. Localization of the procoagulant- and prothrombin-binding domain of this protein. J Biol Chem (1986) 1.12

Structure of coagulation factors IX/X-binding protein, a heterodimer of C-type lectin domains. Nat Struct Biol (1997) 1.11

Derivatives of blood coagulation factor IX contain a high affinity Ca2+-binding site that lacks gamma-carboxyglutamic acid. J Biol Chem (1984) 1.11

A sensitive substrate for the clotting enzyme in horseshoe crab hemocytes. J Biochem (1977) 1.10

Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5' enhancer. J Biol Chem (1998) 1.10

Prevalence of human papillomavirus types 16 and 18 in cervical carcinomas: a study by dot and Southern blot hybridization and the polymerase chain reaction. Jpn J Cancer Res (1990) 1.10

Acute epididymo-orchitis with abscess formation due to Pseudomonas aeruginosa: report of 3 cases. Hinyokika Kiyo (2000) 1.09

Primary structure, developmental expression, and immunolocalization of the murine laminin alpha4 chain. J Biol Chem (1997) 1.09

A new endotoxin sensitive factor associated with hemolymph coagulation system of horseshoe crab (Limulidae). FEBS Lett (1980) 1.09

The primary structure of coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. Homology with asialoglycoprotein receptors, proteoglycan core protein, tetranectin, and lymphocyte Fc epsilon receptor for immunoglobulin E. J Biol Chem (1991) 1.08

Synthesis and nuclease susceptibility of alpha-oligodeoxyribonucleotide phosphorothioate. Nucleic Acids Symp Ser (1991) 1.08

Amyloidosis of a possible new type in patients receiving long-term hemodialysis. Arch Pathol Lab Med (1985) 1.08

Caldesmon suppresses cancer cell invasion by regulating podosome/invadopodium formation. FEBS Lett (2007) 1.08

Cloning of a marsupial DNA photolyase gene and the lack of related nucleotide sequences in placental mammals. Nucleic Acids Res (1994) 1.08

Magnesium(II) is a crucial constituent of the blood coagulation cascade. Potentiation of coagulant activities of factor IX by Mg2+ ions. J Biol Chem (1996) 1.07

Bovine serum albumin (BSA) nephritis in rats. I. Experimental model. Acta Pathol Jpn (1978) 1.07

Protective roles of endogenous carbon monoxide in neointimal development elicited by arterial injury. Am J Physiol Heart Circ Physiol (2000) 1.07

Limulus anti-LPS factor: an anticoagulant which inhibits the endotoxin mediated activation of Limulus coagulation system. Biochem Biophys Res Commun (1982) 1.06

Brain metastases in musculoskeletal sarcomas. Jpn J Clin Oncol (1999) 1.06

Uptake and processing of the precursor for rat liver ornithine transcarbamylase by isolated mitochondria. Inhibition by uncouplers. J Biol Chem (1981) 1.06

Synthesis, intracellular transport, and processing of the precursors for mitochondrial ornithine transcarbamylase and carbamoyl-phosphate synthetase I in isolated hepatocytes. Proc Natl Acad Sci U S A (1981) 1.06

Immunolocalization of Ku-proteins (p80/p70): localization of p70 to nucleoli and periphery of both interphase nuclei and metaphase chromosomes. Exp Cell Res (1992) 1.06

Multiple schwannomas in the peripheral nerves. J Bone Joint Surg Br (1998) 1.05

Intracellular proclotting enzyme in limulus (Tachypleus tridentatus) hemocytes: its purification and properties. J Biochem (1985) 1.05

Detrimental effects of glucocorticoids on neuronal migration during brain development. Mol Psychiatry (2009) 1.04

The palliative care knowledge test: reliability and validity of an instrument to measure palliative care knowledge among health professionals. Palliat Med (2009) 1.04

Mesangiolysis. Kidney Int (1983) 1.04